Bruker Corp. (BRKR) Tops Q3 EPS by 13c; Boosts FY12 Outlook
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $57.93 -2.26%
Financial Fact:
Selling, general and administrative: 96.8M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 96.8M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bruker Corp. (NASDAQ: BRKR) reported Q3 EPS of $0.28, $0.13 better than the analyst estimate of $0.15. Revenue for the quarter came in at $447.8 million versus the consensus estimate of $421.39 million.
Bruker Corp. sees FY2012 EPS of $0.75-0.79, versus the consensus of $0.67. Bruker Corp. sees FY2012 revenue of $1.73-1.76 billion, versus the consensus of $1.73 billion.
For earnings history and earnings-related data on Bruker Corp. (BRKR) click here.
Bruker Corp. sees FY2012 EPS of $0.75-0.79, versus the consensus of $0.67. Bruker Corp. sees FY2012 revenue of $1.73-1.76 billion, versus the consensus of $1.73 billion.
For earnings history and earnings-related data on Bruker Corp. (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
